A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I...

Clinical and Translational Gastroenterology 2019 / 07 Vol. 10; Iss. 7

A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Kelley, R.K., Gane, E., Assenat, E., Siebler, J., Galle, P.R., Merle, P., Hourmand, I.O., Cleverly, A., Zhao, Y., Gueorguieva, I., Lahn, M., Faivre, S., Benhadji, K.A., Giannelli, G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
Clinical and Translational Gastroenterology
DOI:
10.14309/ctg.0000000000000056
Date:
July, 2019
File:
PDF, 602 KB
2019
Conversion to is in progress
Conversion to is failed